Bristol-Myers matches earnings forecast, helped by low taxes
(Reuters) - Bristol-Myers Squibb Co (BMY.N) reported lower first-quarter earnings, in line with forecasts, thanks to unexpectedly lower taxes and sharply higher sales of its treatments for melanoma, leukemia and diabetes.
The company on Thursday said it earned $609 million, or 37 cents per share, in the quarter. That compared with $1.1 billion, or 64 cents per share in the year-earlier period.
(Reporting By Ransdell Pierson; Editing by Gerald E. McCormick)
- China anxiety knocks shares, oil
- NATO countries have begun arms deliveries to Ukraine: defense minister |
- Alibaba worried about Facebook IPO as considered Nasdaq versus NYSE
- North Korea sentences U.S. citizen Matthew Miller to six years hard labor |
- U.S. sees Middle East help fighting IS, Britain cautious after beheading